HCPCS Code Descriptor:
Injection, plasminogen, human-tvmh, 1 mg
Route of Administration:
Potential NDC Listing Errors:
Our team has identified potential listing errors/discrepancies with the following NDCs:
Please contact us regarding potential compendia errors/discrepancies
RYPLAZIM is a Hematology drug manufactured by Kedrion Biopharma and administered via the Intravenous route of administration. The J Code: J2998 is aligned to the drug RYPLAZIM.